The global next generation sequencing (NGS) market is expected to grow at growth rate of 9.1% to reach USD 20.8 billion by 2025.

Next Generation Sequencing (NGS) is a technique that enables the sequencing of thousands of DNA molecules simultaneously. This technique has revolutionized the medical fields, in terms of the treatment of genetic diseases, use of personalized medicines and clinical diagnostic techniques. NGS technology is used for the wide range of sequencing approaches such as transcriptome, genome, and epigenome of any organism. Advancement in technologies has stimulated the uptake of NGS techniques among end-users, leading to driving the market growth. A significant advancement in NGS technology occurred with the introduction of paired-end (PE) sequencing technique. PE sequencing method involves sequencing of DNA fragments at both ends and enables to align the reverse and forward reads as reading pairs. Additionally, producing the twice reads and alignment of reverse and forward read pairs improve accuracy and ability to sequence effectively compared to the single read data. Such introduction is anticipated to stimulate the demand for NGS technologies, augmenting the market growth to great extent.

Companies such as Illumina, Inc., Qiagen, Agilent Technologies, Genomatix GmbH, and Roche are profiles in the study. Among which, Roche and Illumina Inc. accounted for the significant share of the total market. This is majorly attributed to their product offerings to the market of technologically advanced next-generation sequencing platforms such HiSeq and Miseq which are capable of rapidly sequencing whole genomes at relatively less expensive costs.

To access report highlight and table of content of this report, please click the link below:

http://www.analystviewmarketinsights.com/report-highlight-next-generation-sequencing-ngs-market-149/

Key Takeaways :

 Targeted sequencing captured significant share of the global market owing to the significant advantages of it compared to the traditional WGS study

 NGS technique has major applications in oncology wherein it is used to sequence and Catalogue gene mutations for further      development of novel cancer diagnostic and therapeutic methodologies, witnessing the significant increase in demand throughout the future period.

 NGS has emerged as an essential and important tool to understand the altered genetic pathways responsible for the development for cancer.

 The pre-sequencing segment covers products such as NGS library preparation kits, NGS semi-automated library preparation, and clonal amplification. This phase includes the sample preparation processes that are undertaken prior to the sequencing step. In 2017, this segment captured USD 1,345.9 million, growing at significant growth rate.

 Developing regions such as the Asia Pacific and Latin America is projected to grow with the strong growth rate. Growth of these countries is majorly attributed to the significant developments by China and Japan for technological integration of NGS  methodologies, and the development of healthcare, R&D, and clinical development frameworks

KEY BENEFITS OF THE REPORT :

• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation :

NGS MARKET, BY TECHNOLOGY

• Whole Exon Sequencing (WES)
• Whole Genome Sequencing (WGS)
• Targeted Sequencing
• Resequencing Technique

NGS MARKET, BY APPLICATION

• Oncology
• Reproductive Health
• Clinical Investigation
• Consumer Genomics
• Immune Monitoring
• Others

NGS MARKET, BY PRODUCT & SERVICES

• Pre-Sequencing Products
• Sequencing Services
• Data Analysis

NGS MARKET, BY END USE

• Academic Research
• Hospital Settings
• Clinical Laboratories
• Others

NGS MARKET, BY REGION

• North America
• Europe
• Asia Pacific
• Rest of the World

NGS MARKET, BY COUNTRY

• Further Breakdown of The North America Market
  • U.S.
  • Canada
• Further Breakdown of The Europe Market
  • Germany
  • France
  • Rest of Europe
• Further Breakdown of The APAC Market
  • India
  • China
  • Rest of APAC
• Further Breakdown of The Rest of the World Market
  • Middle East and Africa
  • Latin America